Part four of our four-part spotlight on Australia. In this series of short articles, we profile Australia and three of its main cities for life sciences innovation: Melbourne, Brisbane, and Sydney.

Australia - Sydney

New South Wales is home to approximately 200 life science companies and exports over AUD2 billion (USD1.4 billion) in pharmaceuticals and medical devices annually. Among its firms is RNAi developer Benitec, a NASDAQ listed company that has licensed its technology around the world for indications including HIV, cancer, and chronic pain. The multibillion-dollar hearing technology company, Cochlear, has its global headquarters in Sydney. Sydney also is a manufacturing hub for many multinational companies, such as Virbac, Pfizer, MSD, Novartis, and GSK.

The state boasts more than 20 biotechnology-related research institutes, 11 universities, and over 15 teaching hospitals. Australia’s government agency for scientific research, CSIRO, also has a research site within the high-tech hub in northern Sydney. Among the universities based here is the University of Sydney, ranked in the top 100 life science universities worldwide (Times Higher Education rankings). Sleep apnoea treatment company ResMed, another of Australia’s billion dollar listed companies, was founded on University of Sydney technology.

Sydney’s fortes include oncology, medical devices, pharmaceutical manufacturing, and clinical research. George Clinical, the largest contract research organisation in Asia Pacific, is headquartered here. Its parent, The George Institute for Global Health, is consistently placed in the top 10 research institutes worldwide for its scientific impact.

BioPacific Partners in Sydney

Although Sydney does not have its own dedicated biotech industry organisation as in the case of Melbourne and Brisbane, it does possess several other key industry-focused groups. Among them is the Australian Technology Park, home to the business incubator ATP Innovations. Several of our team members were in Sydney last month for meetings with universities, companies, government institutes, venture firms, and incubators such as ATP Innovations. We will be returning to the region often, and not just for the excellent seafood and Italian cuisine!

BioPacific Partners has strong relationships with companies and institutes operating across Australia, providing our Partners with an extended network of their own. We specialise in bridging the best of innovation from this region into global markets so contact us if you think we can help you, or explore our Innovation Portfolio for real examples of our work.

By Emma Armitage and Joerg Kistler, BioPacific Partners

To read all articles in the Spotlight on Australian life sciences series, see the profiles for  Melbourne, Brisbane and Adelaide.

About Emma Armitage

No Comments

Be the first to start a conversation

Leave a Reply

  • (will not be published)